HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M
Source: SeekingAlpha
2025-11-14 17:26:30 ET
More on HCW Biologics
- Seeking Alpha’s Quant Rating on HCW Biologics
- Historical earnings data for HCW Biologics
- Financial information for HCW Biologics
Read the full article on Seeking Alpha
For further details see:
HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M
HCW Biologics Inc.
NASDAQ: HCWB
HCWB Trading
-1.38% G/L:
$0.508 Last:
8,812 Volume:
$0.55 Open:
HCWB Latest News
March 02, 2026 08:00:00 am
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter
February 17, 2026 09:50:56 pm
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
February 13, 2026 08:30:00 am
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
November 19, 2025 08:30:00 am
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
HCWB Stock Data
$3,329,009
2,663,207
40.46%
4
N/A
Biotechnology & Life Sciences
Healthcare
US
Miramar
